Corina Becker

1.2k total citations
54 papers, 966 citations indexed

About

Corina Becker is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Corina Becker has authored 54 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Corina Becker's work include Cardiac electrophysiology and arrhythmias (12 papers), Pulmonary Hypertension Research and Treatments (12 papers) and Heart Failure Treatment and Management (11 papers). Corina Becker is often cited by papers focused on Cardiac electrophysiology and arrhythmias (12 papers), Pulmonary Hypertension Research and Treatments (12 papers) and Heart Failure Treatment and Management (11 papers). Corina Becker collaborates with scholars based in Germany, United States and Netherlands. Corina Becker's co-authors include Jennifer Dressman, Wolfgang Mück, Reiner Frey, D.M. Barends, Hans E. Junginger, Vinod P. Shah, S. Stavchansky, Sabine Kopp, K.K. Midha and Sigrun Unger and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

Corina Becker

53 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Corina Becker Germany 17 267 221 198 168 134 54 966
Barbara Schug Germany 16 72 0.3× 272 1.2× 70 0.4× 151 0.9× 129 1.0× 47 991
Kirstin Thelen Germany 20 156 0.6× 248 1.1× 57 0.3× 191 1.1× 111 0.8× 26 1.3k
Gérard Flesch Switzerland 19 209 0.8× 94 0.4× 80 0.4× 102 0.6× 136 1.0× 30 1.3k
Lawrence S. Olanoff United States 17 88 0.3× 162 0.7× 95 0.5× 123 0.7× 82 0.6× 27 823
Gangadhar Sunkara United States 22 261 1.0× 67 0.3× 118 0.6× 210 1.3× 81 0.6× 71 1.0k
Yoh Takekuma Japan 20 74 0.3× 122 0.6× 80 0.4× 250 1.5× 70 0.5× 156 1.3k
Man‐Wai Lo United States 19 418 1.6× 32 0.1× 113 0.6× 187 1.1× 215 1.6× 43 1.4k
A. Sioufi Switzerland 23 225 0.8× 91 0.4× 99 0.5× 209 1.2× 351 2.6× 73 1.5k
Chyung S. Cook United States 13 111 0.4× 268 1.2× 45 0.2× 200 1.2× 65 0.5× 29 850
Wen Chyi Shyu United States 23 104 0.4× 120 0.5× 102 0.5× 408 2.4× 129 1.0× 78 1.6k

Countries citing papers authored by Corina Becker

Since Specialization
Citations

This map shows the geographic impact of Corina Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corina Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corina Becker more than expected).

Fields of papers citing papers by Corina Becker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corina Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corina Becker. The network helps show where Corina Becker may publish in the future.

Co-authorship network of co-authors of Corina Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Corina Becker. A scholar is included among the top collaborators of Corina Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corina Becker. Corina Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frechen, Sebastian, Ibrahim Ince, André Dallmann, et al.. (2023). Applied physiologically‐based pharmacokinetic modeling to assess uridine diphosphate‐glucuronosyltransferase‐mediated drug–drug interactions for Vericiguat. CPT Pharmacometrics & Systems Pharmacology. 13(1). 79–92. 7 indexed citations
2.
Düngen, Hans‐Dirk, Frank Donath, Rainard Fuhr, et al.. (2023). Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes. American Journal of Cardiovascular Drugs. 23(2). 145–155. 9 indexed citations
3.
Solms, Alexander, et al.. (2023). Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling Approaches. Clinical Pharmacokinetics. 62(11). 1639–1648. 1 indexed citations
4.
Böettcher, Michael, Hans‐Dirk Düngen, Frank Donath, et al.. (2022). Vericiguat in Combination with Short‐Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study. Clinical Pharmacology & Therapeutics. 111(6). 1239–1247. 9 indexed citations
5.
Böettcher, Michael, et al.. (2020). Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects. European Journal of Clinical Pharmacology. 77(4). 527–537. 49 indexed citations
6.
Böettcher, Michael, et al.. (2020). Pharmacodynamic and Pharmacokinetic Interaction Profile of Vericiguat: Results from Three Randomized Phase I Studies in Healthy Volunteers. Clinical Pharmacokinetics. 60(3). 337–351. 21 indexed citations
7.
Böettcher, Michael, Michael Gerisch, Maximilian T. Lobmeyer, et al.. (2020). Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies. Clinical Pharmacokinetics. 59(11). 1407–1418. 41 indexed citations
8.
Donath, Frank, et al.. (2017). Abstract 19938: VEriciguat NItroglycerin Clinical IntEraction (VENICE): A Phase 1, Multicenter, Randomized, Placebo-controlled, Double-blind Group-comparison Study in Patients With Stable Coronary Artery Disease to Evaluate Tolerability and Blood Pressure Effects of Nitroglycerin After Pre-treatment With Multiple Oral Doses of Vericiguat. Circulation. 3 indexed citations
9.
Saleh, Soundos, Corina Becker, Reiner Frey, & Wolfgang Mück. (2016). Population Pharmacokinetics and the Pharmacokinetic/Pharmacodynamic Relationship of Riociguat in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension. Pulmonary Circulation. 6(S1). S86–96. 13 indexed citations
10.
Becker, Corina, Reiner Frey, Christiane Hesse, et al.. (2016). Absorption of Riociguat (BAY 63‐2521): Bioavailability, Food Effects, and Dose Proportionality. Pulmonary Circulation. 6(S1). S27–34. 12 indexed citations
11.
Saleh, Soundos, Corina Becker, Reiner Frey, & Wolfgang Mück. (2016). Population Pharmacokinetics of Single‐Dose Riociguat in Patients with Renal or Hepatic Impairment. Pulmonary Circulation. 6(S1). S75–85. 12 indexed citations
12.
Becker, Corina, Reiner Frey, Sigrun Unger, et al.. (2016). Pharmacokinetic Interaction of Riociguat with Ketoconazole, Clarithromycin, and Midazolam. Pulmonary Circulation. 6(S1). 24 indexed citations
13.
14.
Frey, Reiner, Corina Becker, Sigrun Unger, et al.. (2016). Assessment of the Effects of Renal Impairment and Smoking on the Pharmacokinetics of a Single Oral Dose of the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63‐2521). Pulmonary Circulation. 6(S1). S15–26. 22 indexed citations
15.
Becker, Corina, et al.. (2016). Effects of Omeprazole and Aluminum Hydroxide/Magnesium Hydroxide on Riociguat Absorption. Pulmonary Circulation. 6(S1). S43–8. 8 indexed citations
16.
Saleh, Soundos, Reiner Frey, Corina Becker, et al.. (2016). Bioavailability, Pharmacokinetics, and Safety of Riociguat Given as an Oral Suspension or Crushed Tablet with and without Food. Pulmonary Circulation. 6(S1). S66–74. 9 indexed citations
17.
Becker, Corina, Reiner Frey, Sigrun Unger, et al.. (2013). Pharmacokinetic (PK) interaction of ketoconazole (KC), clarithromycin (CM) and midazolam (MZ) with riociguat. European Respiratory Journal. 42(Suppl 57). P4068–P4068. 1 indexed citations
18.
Willmann, Stefan, Corina Becker, Rolf Burghaus, et al.. (2013). Development of a Paediatric Population-Based Model of the Pharmacokinetics of Rivaroxaban. Clinical Pharmacokinetics. 53(1). 89–102. 66 indexed citations
19.
Becker, Corina, Jennifer Dressman, Hans E. Junginger, et al.. (2009). Biowaiver monographs for immediate release solid oral dosage forms: Rifampicin. Journal of Pharmaceutical Sciences. 98(7). 2252–2267. 64 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Schug Breakdown of academic impact, for papers by Kirstin Thelen Breakdown of academic impact, for papers by Gérard Flesch Breakdown of academic impact, for papers by Lawrence S. Olanoff Breakdown of academic impact, for papers by Gangadhar Sunkara Breakdown of academic impact, for papers by Yoh Takekuma Breakdown of academic impact, for papers by Man‐Wai Lo Breakdown of academic impact, for papers by A. Sioufi Breakdown of academic impact, for papers by Chyung S. Cook Breakdown of academic impact, for papers by Wen Chyi Shyu
Rankless by CCL
2026